Antimalarial drug chloroquine suppresses KSHV lytic gene expression and virion production.
Chloroquine shows cytotoxicity toward KSHV lytically infected B cells at clinically acceptable doses.
Chloroquine interferes with mTOR and MAPK activation during lytic replication but not latent infection.